Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Distinct risk groups with different healthcare barriers and acute care use exist in the U.S. population with chronic liver disease

  • Carrie R. Wong ,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing

    crwong@mednet.ucla.edu

    Affiliations Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, California, United States of America, Kaiser Permanente Center for Health Equity, University of California, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, United States of America, Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California, United States of America

  • Catherine M. Crespi,

    Roles Conceptualization, Methodology, Supervision, Writing – review & editing

    Affiliations Kaiser Permanente Center for Health Equity, University of California, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, United States of America, Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, United States of America

  • Beth Glenn,

    Roles Conceptualization, Methodology, Supervision, Writing – review & editing

    Affiliations Kaiser Permanente Center for Health Equity, University of California, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, United States of America, Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California, United States of America

  • Steven-Huy B. Han,

    Roles Conceptualization, Writing – review & editing

    Affiliation Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, California, United States of America

  • James A. Macinko,

    Roles Conceptualization, Methodology, Supervision, Validation, Writing – review & editing

    Affiliations Kaiser Permanente Center for Health Equity, University of California, Los Angeles, California, United States of America, Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California, United States of America, Department of Community Health Sciences, Fielding School of Public Health, University of California, Los Angeles, California, United States of America

  • Roshan Bastani

    Roles Conceptualization, Methodology, Supervision, Writing – review & editing

    Affiliations Kaiser Permanente Center for Health Equity, University of California, Los Angeles, California, United States of America, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, United States of America, Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California, United States of America

Abstract

Background

The relationship between community-based healthcare barriers and risk of recurrent hospital-based care among persons with chronic liver disease (CLD) is understudied. We aimed to uncover distinct groups among adults in the United States with CLD based on healthcare barriers and risk-stratify recurrent acute care use by group.

Methods

Using National Health Interview Survey (2011 to 2017) data, we performed latent class analysis (LCA) to uncover groups experiencing distinct sets of healthcare barriers. We assessed sociodemographic and health characteristics and probabilities of recurrent acute care use by group.

Results

The sample included 5,062 (estimated 4.7 million) adults with CLD (median [range] age 55 [18–85]). LCA modeling differentiated 4 groups: minimal barriers (group 1) (n = 3,953; 78.1%), unaffordability (group 2) (n = 540; 10.7%), care delays (group 3) (n = 328; 6.5%), and inability to establish care (group 4) (n = 240; 4.8%). Group 2 had the most uninsured persons (n = 210; 38.9%), whereas group 3 was mostly insured (n = 305; 93.1%). Group 4 included the most adults under 65 years old (n = 220; 91.7%), females (n = 156; 65.1%), and persons with unemployment (n = 169; 70.6%) and poverty (n = 85; 35.3%). Compared to group 1, the likelihood of recurrent acute care use was highest for group 4 (aOR, 1.85; 95% CI, 1.23–2.79 followed by group 3 (aOR, 1.50; 95% CI, 1.07–2.11) and group 2 (aOR, 1.48; 95% CI, 1.11–1.97).

Conclusion

US adults with CLD can be categorized into 4 distinct groups based on healthcare barriers, which are associated with different probabilities of recurrent acute care use. Findings from this study are important for future interventions to reduce potentially avoidable hospital-based care among the highest-risk persons with CLD.

Introduction

Rates of hospitalizations have disproportionately increased for individuals with chronic liver disease (CLD) [13]. Accordingly, there have been efforts to predict and reduce hospitalizations for persons with CLD; however, prior work has shown modest predictive accuracy (C-statistics 0.60–0.75) [49]. These predictive algorithms have largely focused on hospital-based clinical variables which may have limited their predictive yield after hospital discharge.

Attention to non-hospital-based factors, specifically one’s experience with healthcare barriers in the community setting, can provide new knowledge on the potential influence of outpatient access to care on recurrent acute care use. Care coordination programs have shown that frequent interactions with providers in the ambulatory setting [10] and post-discharge home visits [1113] have successfully reduced rehospitalizations, potentially through the elimination of some healthcare barriers in the care seeking process.

Emerging data have shown that specific healthcare barriers, including healthcare unaffordability [14] and transportation insecurity [15], among adults in the United States (US) with CLD are associated with increased likelihood of acute care use. However, the relative risk of different healthcare barriers on recurrent acute care use and the sociodemographic and health characteristics of persons who share unique patterns of barriers among the US adult population with CLD remain unknown.

To our knowledge, identification of distinct risk groups for recurrent acute care in the US adult population with CLD using community-based healthcare barriers has not been done. In this study, we used National Health Interview Survey (NHIS) data to perform latent class analysis (LCA) to uncover risk groups based on self-reported healthcare barriers among respondents with CLD. We then evaluated the likelihood of latent class (risk group) membership by sociodemographic, health, and insurance characteristics and measured the probability of recurrent acute care use by risk group.

Methods

Data source

We pooled annual NHIS data, from 2011 to 2017, to conduct a cross-sectional study that yielded nationally representative estimates from noninstitutionalized, community-dwelling persons residing in the 50 states and District of Columbia at the time of the interview [16]. NHIS is an annual in-person household interview that collects data about sociodemographic and health status [16]. Study years were selected to capture healthcare experiences after the enactment of the Affordable Care Act. NHIS no longer surveyed specific healthcare barriers in 2018. We used the Sample Adult file, which included responses from randomly selected adults per randomly selected household. During this study period, the mean conditional response and final response rates were 80.7% and 60.4%, respectively.

The institutional review board at the University of California, Los Angeles exempted this study from review for the use of de-identified and publicly available data from the Integrated Public Use Microdata Series Health Surveys [17]. The study follows the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.

Study population

Our study population consisted of respondents aged 18 years or older with CLD, which included persons who responded yes to the questions, “Has a doctor or other health professional ever told you that you had any kind of chronic, or long-term liver condition” or “During the past 12 months, have you been told by a doctor or other health professional that you had any kind of liver condition?” as previously done [14, 15] (Fig 1).

thumbnail
Fig 1. Study population flowchart.

Chronic liver disease was based on yes responses to the following questions: “Has a doctor or other health professional ever told you that you had any kind of chronic, or long-term liver condition?” or “During the past 12 months, have you been told by a doctor or other health professional that you had any kind of liver condition?”.

https://doi.org/10.1371/journal.pone.0311077.g001

Measures

We selected self-reported healthcare barriers that spanned the care seeking process including organizational barriers and healthcare unaffordability. Respondents were considered to have a healthcare barrier if they responded yes to any of the following questions in the past year:

  1. 1. “Were you told by a doctor’s office or clinic that they would not accept you as a new patient?”
  2. 2. “Were you told by a doctor’s office or clinic that they did not accept your healthcare coverage?”
  3. 3. “Did you have any trouble finding a general doctor or provider who would see you?”
  4. 4. “Was there any time when you needed medical care but did not get it because of the cost?”
  5. 5. “Was there any time when you needed any of the following, but didn’t get it because you couldn’t afford it …follow-up care?”
  6. 6. “Was there any time when you needed any of the following, but didn’t get it because you couldn’t afford it …to see a specialist?”
  7. 7. “Was there any time when you needed any of the following, but didn’t get it because you couldn’t afford it …prescription medicines?”
  8. 8. “Have you delayed getting care for any of the following reasons in the past 12 months? …You didn’t have transportation?”
  9. 9. “Have you delayed getting care for any of the following reasons in the past 12 months? …You couldn’t get an appointment soon enough?”
  10. 10. “Have you delayed getting care for any of the following reasons in the past 12 months? …The clinic/ doctor’s office wasn’t open when you could get there?”
  11. 11. “Have you delayed getting care for any of the following reasons in the past 12 months? …You couldn’t get through on the telephone?”
  12. 12. “Have you delayed getting care for any of the following reasons in the past 12 months? …Once you get there, you have to wait too long to see the doctor?”

We also included any respondents who responded no to the following question:

  1. 13. “Is there a place that you usually go to when you are sick or need advice about your health?”

We assessed a parsimonious set of covariates about the respondents’ sociodemographic, health, and insurance status based on reported associations between the covariates and healthcare experiences: age, sex, race or ethnicity (Hispanic, Non-Hispanic [NH] White, NH Black/ African-American, NH Asian, NH American Indian/ Alaskan Native, NH Other) [18, 19], number of comorbidities [20, 21], functional limitation due to health [22, 23], fair or poor health (vs. excellent, very good, or good health) [24, 25], education attainment (less than vs. at least high school graduate level education) [26], employment (working vs. not working in the past year) [27], household poverty (less than or at least 200% of the federal poverty level [FPL]) [16], household support (i.e. living alone) [28], and health insurance, which included public (Medicaid, other state-sponsored insurance), Medicare (without Medicaid or other state-sponsored insurance), private, or none [29, 30].

We included respondents’ report of recurrent acute care use defined as having at least two emergency department (ED) visits and/or overnight hospital admissions for any cause in the past year. We did not limit hospital-based acute care to readmissions because up to 40% of recurrent acute care encounters within 30 days of a hospital discharge could occur in the ED without readmission [31].

Statistical analysis

We conducted LCA to uncover unique groups of persons with CLD in the US population. These groups are the latent classes, which are derived from patterns and probabilities of responses to a set of variables (i.e. questions about different healthcare barriers) [32] (Fig 2).

thumbnail
Fig 2. Analytic model for latent class analysis.

Identification of unique risk groups (latent classes) was based on the pattern and probability of responses to the 13 questions about different healthcare barriers. The association between different risk groups and recurrent acute care use was then assessed by adjusting for covariates.

https://doi.org/10.1371/journal.pone.0311077.g002

We used a sequential exploratory approach by fitting different models with a successively increasing number of latent classes starting with one class (k = 1, 2, 3, 4, 5, 6) to determine the most appropriate model [3841]. The best fitting LCA model was chosen based on the most favorable fit statistics, which included Akaike’s information criterion (AIC), consistent Akaike’s information criterion (CAIC), and Bayesian information criterion (BIC) [33, 34]. We supplemented the fit statistics with assessments of optimal sample size per class [34], classification diagnostics, including the average posterior probability [APP] and entropy value [3437], along with conceptual interpretability as previously done [38]. We defined appropriate model fit using APP and entropy values above 0.8 [3437].

After identifying the optimal model, we tabulated the prevalence of different healthcare barriers and sociodemographic and health covariates by risk group. Significance testing was performed using Chi-squared (categorical variables) or adjusted Wald tests (continuous variables). We used multinomial logistic regression to predict membership in each risk group and likelihood of recurrent acute care use by risk group. We adjusted for sociodemographic, health, and insurance covariates that were significantly different among the risk groups. Our stratified analysis evaluated the association between the risk groups and recurrent acute care use by insurance type using multivariable logistic regression. Probabilities were obtained from the regression models.

All analyses were performed using Stata SE version 18.0 (StataCorp). Descriptive statistics and regression analyses were performed using the Stata–svy- command to produce nationally representative estimates. While the study population only included those with CLD, all respondents in the Sample Adult file were included in the analysis to ensure accuracy in population-level point estimates and standard errors. Fit and diagnostic statistics were obtained using unweighted data to obtain likelihood ratios. Statistical significance was defined as a 2-sided p-value of less than 0.05.

Results

Study population characteristics

The sample included 5,062 adults which provided estimates for 4,742,444 persons with CLD. Over half of the sample was female (51.5%) and non-Hispanic White (65.8%) with a median age (range) of 55 (18–85) years (Table 1). The adult population with CLD had a median number of 2 (0–9) comorbidities and suboptimal perceived health as demonstrated by rates of fair or poor health (41.4%) and the presence of a functional limitation due to health (68.2%). Most respondents had at least a high school graduate level of education (92.8%) and were not employed (57.8%). Household poverty was identified among 20.1% of respondents. About a quarter of respondents lived alone (23.2%). Half of the adult CLD population had private insurance (50.0%), followed by public insurance (23.6%), Medicare (15.3%), and no insurance (11.2%).

thumbnail
Table 1. Sociodemographic and health characteristics of the total sample and by risk group (N = 5,062).

https://doi.org/10.1371/journal.pone.0311077.t001

Selection of the optimal latent class model

The fit statistics (AIC, CAIC, BIC) favored the models with the larger number of classes (Table 2). However, the models with five or six classes had small latent classes. The smallest APP and entropy values demonstrated acceptable model fit for models with two to four latent classes, defined as APP and entropy values greater than 0.8. As such, the best fitting latent class model identified four unique groups.

thumbnail
Table 2. Model selection using fit and diagnostic statistics.

https://doi.org/10.1371/journal.pone.0311077.t002

Four risk groups identified by LCA

The risk groups were categorized as follows: group 1 represented 3,703,788 persons with CLD (78.1%) who had the lowest frequency of barriers (minimal barriers), group 2 represented 506,347 respondents (10.7%) with frequent experiences with healthcare unaffordability (unaffordability), group 3 represented 307,013 persons (6.5%) with the most organizational barriers within healthcare (care delays), and group 4 represented 225,296 adults (4.8%) who had frequent organizational barriers at entry to healthcare (inability to establish care) (Fig 3 and Table 3). In group 2 (unaffordability), the vast majority of respondents could not afford specialty care (78.5%). The most common barrier among individuals in group 3 (care delays) was inability to secure a timely appointment (90.1%). In group 4 (inability to establish care), the predominant healthcare barrier was being declined as a new patient (95.0%).

thumbnail
Fig 3. Prevalence of healthcare barriers in the four group latent class model (N = 5,062).

Source: National Health Interview Survey, 2011–2017. Weighted prevalence is reported for each risk group (latent class) on the y-axis. Specific barriers are included on the x-axis. The largest group, minimal barriers (light solid line), included a sample of 3,953 (weighted 3,703,788) adults with chronic liver disease who had the lowest frequency of healthcare barriers. The second largest group, unaffordability (dark solid line), included 540 (weighted 506,347) adults who reported frequent challenges affording healthcare. The third largest group, care delays (dotted line), consisted of 328 (weighted 307,013) adults who reported having delays in care due to organizational barriers within the healthcare system. The fourth group, inability to establish care (dash line), included 240 (weighted 225,296) adults who reported having frequent barriers at entry to healthcare.

https://doi.org/10.1371/journal.pone.0311077.g003

thumbnail
Table 3. Prevalence of health care barriers in the total sample and by risk group (N = 5,062).

https://doi.org/10.1371/journal.pone.0311077.t003

Risk group characteristics and membership

Group 1 (minimal barriers) consisted of older adults (median age [range] 56 [18–85] years) with the lowest proportion with fair or poor health (36.9%), functional limitation due to health (64.6%), unemployment (56.4%), poverty (17.4%), and uninsurance (7.7%) (Table 1). Group 2 (unaffordability) included the youngest persons (median age [range] 50 [19–81] years) and had the largest proportion of uninsured respondents (38.9%) compared to the other risk groups. Group 3 (care delays) was mostly insured (93.1%), had a higher rate of fair or poor health (61.6%), and included a larger proportion of respondents who identified as non-White, including Hispanics (23.3%), compared to other groups. Group 4 (inability to establish care) was predominantly female (65.1%) with more functional limitation due to health (84.6%), unemployment (70.6%), poverty (35.3%), and public health insurance enrollees (39.2%).

After adjusting for sociodemographic and health characteristics, we found that membership in group 2 (unaffordability) was mainly insurance-driven (Table 4). Compared to the uninsured, persons in group 2 (unaffordability) were significantly more likely to have Medicare (adjusted rate ratio [aRRR], 0.26; 95% CI, 0.16–0.42), followed by private (aRRR, 0.14; 95% CI, 0.09–0.21) and public insurance (aRRR 0.12; 95% CI, 0.08–0.19). The most salient characteristics that contributed to membership into group 3 (care delays) were health-related, specifically fair or poor health (aRRR, 1.89; 95% CI, 1.29–2.77) and functional limitation due to health (aRRR, 2.54, 95% CI, 1.57–4.13). Notably, Hispanics were significantly more likely to be in group 3 (care delays) (aRRR, 1.62; 95% CI, 1.11–2.35). Membership in group 4 (inability to establish care) was also significantly associated with functional limitation due to health (aRRR, 2.59; 95% CI, 1.54–4.36) although female sex (aRRR, 1.84; 95% CI, 1.24–2.74, P = 0.003) was uniquely associated with this group.

thumbnail
Table 4. Association of Sociodemographic and health characteristics and risk group membership (n = 4,646).

https://doi.org/10.1371/journal.pone.0311077.t004

Association between group membership and recurrent acute care use

Group 4 (inability to establish care) had the highest likelihood (adjusted odds ratio [aOR], 1.85; 95% CI, 1.23–2.79) of recurrent acute care use (Table 5 and Fig 4). Our stratified analysis by insurance demonstrated similar results for recurrent acute care use and risk group (Fig 5). Group 4 (inability to establish care) had the highest probability of recurrent hospital and/or ED use compared to the other groups for all insurance types. Those with public insurance had the highest likelihood of recurrent acute care use compared to the other insurance types.

thumbnail
Fig 4. Adjusted probability of recurrent acute care use by risk group.

Source: National Health Interview Survey, 2011–2017. Abbreviations: aOR, adjusted odds ratio. All estimates are from a weighted sample. Probabilities of recurrent acute care use (y-axis) are obtained from a logistic regression model (n = 4,645) that adjusted for sex, age, race or ethnicity, number of comorbidities, fair or poor health, functional limitation due to health, employment, poverty, and insurance. Adjusted probabilities of recurrent acute care use are reported for each risk group (x-axis). Compared to the reference group (minimal barriers), the aOR were as follows: group 2 (affordability) aOR, 1.48; 95% CI, 1.11–1.97; P = 0.007; group 3 (care delays) aOR, 1.50; 95% CI, 1.07–2.11; P = 0.019); group 4 (inability to establish care) aOR 1.85; 95% CI, 1.23–2.79; P = 0.003.

https://doi.org/10.1371/journal.pone.0311077.g004

thumbnail
Fig 5. Adjusted probability of recurrent acute care use by risk group and insurance.

Source: National Health Interview Survey, 2011–2017. Abbreviations: aOR, adjusted odds ratio. All estimates are from a weighted sample. Probabilities of recurrent acute care use (y-axis) are obtained from a logistic regression model (n = 4,645) that adjusted for sex, age, race or ethnicity, number of comorbidities, fair or poor health, functional limitation due to health, employment, poverty, and insurance. Adjusted probabilities of recurrent acute care use are reported for each risk group (x-axis) and by insurance type. Compared to the reference group (minimal barriers), the aOR were as follows: group 2 (affordability) aOR, 1.48; 95% CI, 1.11–1.97; P = 0.007; group 3 (care delays) aOR, 1.50; 95% CI, 1.07–2.11; P = 0.019); group 4 (inability to establish care) aOR 1.85; 95% CI, 1.23–2.79; P = 0.003.

https://doi.org/10.1371/journal.pone.0311077.g005

thumbnail
Table 5. Odds ratios and predicted probabilities of recurrent acute care use by risk group.

https://doi.org/10.1371/journal.pone.0311077.t005

Discussion

In this population-based study representative of US adults with CLD, we uncovered four unique risk groups based on self-reported healthcare barriers using LCA. This study built upon previous work [39] that highlighted socioeconomic and health vulnerabilities among US adults with CLD by identifying unique risk groups that shared different sociodemographic and health characteristics and risks of recurrent acute care use. This study provides new evidence and practice and policy implications.

First, our results highlight respondents in group 4 (inability to establish care) who are at particularly high risk of recurrent acute care use. Compared to the larger CLD population in group 1 (minimal barriers), respondents with the highest frequency of organizational barriers at entry to healthcare were 85% more likely to have recurrent acute care use, an estimate that was approximately 35% greater than groups 2 (unaffordability) and 3 (care delays). Females were uniquely associated with membership in group 4 (inability to establish care), which could be related to patient preferences for gender-concordant care [40] in the setting of a predominantly male physician workforce in the US [41]. Future efforts that aim to reduce potentially avoidable recurrent hospital-based care may have a larger effect by prioritizing respondents, particularly females, in group 4 (inability to establish care).

Our stratified analysis by insurance type revealed that the highest risk of recurrent acute care use occurred in the setting of public health insurance. This finding resonates with a meta-analysis that revealed a two- and three-fold lower likelihood of successful securement of medical appointments for primary and specialty care, respectively, for Medicaid compared with private insurance [42]. Future interventions that aim to mitigate organizational barriers at entry to healthcare for persons with CLD are encouraged to evaluate insurer-level policies and advocate to expand the provider network for state-sponsored insurance plans.

Second, group 3 (care delays) demonstrated that untimely receipt of medical care, despite having health insurance, was associated with a 50% higher likelihood of recurrent hospitalization or ED usage compared to group 1 (minimal barriers) similar to prior studies [19, 43]. We found a greater proportion of individuals who identified as non-White in group 3 (care delays), which resonates with previously reported trends in racial and ethnicity disparities in receipt of timely medical care [19]. As membership in group 3 (care delays) was significantly associated with more comorbidities, functional limitation due to health, and fair or poor health status, this group may be capturing individuals with more complex healthcare needs that are inadequately addressed by current system-level resources, including limited availability of appointments as shared amongst 90% of respondents in this group.

Third, this study identified approximately 11% of the US population with CLD that could be categorized in group 2 (unaffordability) consistent with prior studies [14, 44]. Our findings are unique because we found that insurance played the most significant role in predicting membership in group 2 (unaffordability) compared to other groups. In addition to capturing the largest group of uninsured persons in this group (38.9% uninsured), we found that Medicare, followed by private and public insurance were strongly associated with membership in group 2 (unaffordability) similar to previous reports about higher rates of medical indebtedness from private insurance plans with high-deductibles [45] compared to public insurance plans [30]. Interventions that target healthcare unaffordability among US adults with CLD are encouraged to first, reduce the prevalence of uninsurance in this disease population, and second, to decipher specific insurance plans for individuals’ healthcare needs in the setting of their unique socioeconomic circumstances.

Limitations

The study is limited in several ways. First, the study is a pooled, cross-sectional study that cannot draw causal inferences. Findings are meant to highlight significant associations and risk-stratify previously undifferentiated groups of persons with CLD in the larger US adult population. Second, the study is unable to capture the etiology and severity of CLD. While we were unable to discern the causes and severity of CLD in our study, we adjusted for self-reported fair or poor health, which has been a validated measurement to personally assess one’s overall health and severity of illnesses which may motivate one to seek medical care [24, 25]. We also adjusted for functional limitation due to health to capture the severity of health-related physical impairments as most community-dwelling persons seek acute care for concerning symptoms [22, 23]. A third limitation of this study is its lack of detailed information about health insurance plans (e.g. Medicare Advantage vs. Traditional Medicare). Inclusion of coverage details will be informative in future studies. A fourth limitation is the study period, which lacks more recent experiences about different healthcare barriers. Nonetheless, this study period provides the most currently available nationally representative data about specific healthcare barriers that were no longer captured in the NHIS starting in 2018, which remain informative in the development of future interventions to mitigate healthcare barriers for US adults with CLD. Additionally, findings from this study are based on community-dwelling, noninstitutionalized persons who knew about having CLD, which limits the generalizability of the study’s findings to all US adults with CLD. Persons in institutionalized settings (e.g. nursing homes, hospitals) and correctional and treatment facilities (e.g. prisons, rehabilitation centers) or who are homeless and persons who are unaware about having CLD are not captured in this study. Therefore, interpretation this study’s findings are conditional on these limitations.

Conclusions

In conclusion, this population-based study representative of over 4.7 million US adults with CLD is the first to employ LCA to uncover four unique risk groups using self-reported, community-based healthcare barriers. This study differentiates distinct risk groups from patterns of healthcare barriers and identifies relative risks of recurrent acute care use by these distinct groups for persons with CLD. Our results can be leveraged in future prioritization efforts that aim to reduce avoidable recurrent acute care among the most vulnerable persons with CLD, particularly those who frequently face organizational barriers at entry to healthcare.

Supporting information

Acknowledgments

Office of Advanced Research Computing Statistical Methods and Data Analytics Group at the University of California, Los Angeles.

References

  1. 1. Asrani SK, Kouznetsova M, Ogola G, Taylor T, Masica A, Pope B, et al. Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004–2013. Gastroenterology. 2018;155:719–729.e4. pmid:29802851
  2. 2. Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open. 2020;3:e201997. pmid:32239220
  3. 3. Stepanova M, De Avila L, Afendy M, Younossi I, Pham H, Cable R, et al. Direct and Indirect Economic Burden of Chronic Liver Disease in the United States. Clin Gastroenterol Hepatol. 2017;15:759–766.e5.
  4. 4. Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR, Nguyen J, et al. Incidence and Predictors of 30-Day Readmission Among Patients Hospitalized for Advanced Liver Disease. Clin Gastroenterol Hepatol. 2011;9:254–9. pmid:21092762
  5. 5. Singal AG, Rahimi RS, Clark C, Ma Y, Cuthbert JA, Rockey DC, et al. An Automated Model Using Electronic Medical Record Data Identifies Patients With Cirrhosis at High Risk for Readmission. Clin Gastroenterol Hepatol. 2013;11: pmid:23591286
  6. 6. Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard Assessments of Frailty are Validated Predictors of Mortality in Hospitalized Patients with Cirrhosis. Hepatology. 2015;62:584–90. pmid:25846824
  7. 7. Garg SK, Goyal H, Obaitan I, Shah PA, Sarvepalli S, Jophlin LL, et al. Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database. Ann Transl Med. 2021;9:1052. pmid:34422964
  8. 8. Hu C, Anjur V, Saboo K, Reddy KR, O’Leary J, Tandon P, et al. Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis. Official journal of the American College of Gastroenterology | ACG. 2021;116:336. pmid:33038139
  9. 9. Orman ES, Ghabril MS, Desai AP, Nephew L, Patidar KR, Gao S, et al. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022;20:e1426–37. pmid:34311111
  10. 10. Peikes D, Chen A, Schore J, Brown R. Effects of Care Coordination on Hospitalization, Quality of Care, and Health Care Expenditures Among Medicare Beneficiaries: 15 Randomized Trials. JAMA. 2009;301:603. pmid:19211468
  11. 11. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure. New England Journal of Medicine. 1995;333:1190–5. pmid:7565975
  12. 12. Naylor MD, Brooten D, Campbell R, Jacobsen BS, Mezey MD, Pauly MV, et al. Comprehensive Discharge Planning and Home Follow-up of Hospitalized EldersA Randomized Clinical Trial. JAMA. 1999;281:613–20. pmid:10029122
  13. 13. Naylor MD, Brooten DA, Campbell RL, Maislin G, McCauley KM, Schwartz JS. Transitional Care of Older Adults Hospitalized with Heart Failure: A Randomized, Controlled Trial. Journal of the American Geriatrics Society. 2004;52:675–84. pmid:15086645
  14. 14. Lago‐Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States. Hepatology. 2021;74:1509. pmid:33772833
  15. 15. Ufere NN, Lago-Hernandez C, Alejandro-Soto A, Walker T, Li L, Schoener K, et al. Health care–related transportation insecurity is associated with adverse health outcomes among adults with chronic liver disease. Hepatology Communications. 2024;8:e0358. pmid:38206200
  16. 16. NHIS—About the National Health Interview Survey [Internet]. 2023 [cited 2024 Jan 25]. https://www.cdc.gov/nchs/nhis/about_nhis.htm
  17. 17. Blewett LA, Drew JAR, King ML, Williams KCW, Del Ponte N, Convey P. IPUMS Health Surveys: National Health Interview Survey, Version 7.1 [dataset]. Minneapolis, MN: IPUMS; 2021.
  18. 18. Mahajan S, Caraballo C, Lu Y, Valero-Elizondo J, Massey D, Annapureddy AR, et al. Trends in Differences in Health Status and Health Care Access and Affordability by Race and Ethnicity in the United States, 1999–2018. JAMA. 2021;326:637–48. pmid:34402830
  19. 19. Caraballo C, Ndumele CD, Roy B, Lu Y, Riley C, Herrin J, et al. Trends in Racial and Ethnic Disparities in Barriers to Timely Medical Care Among Adults in the US, 1999 to 2018. JAMA Health Forum. 2022;3:e223856. pmid:36306118
  20. 20. Rodrigues LP, de Oliveira Rezende AT, Delpino FM, Mendonça CR, Noll M, Nunes BP, et al. Association between multimorbidity and hospitalization in older adults: systematic review and meta-analysis. Age Ageing. 2022;51:afac155. pmid:35871422
  21. 21. Wolff JL, Starfield B, Anderson G. Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly. Archives of Internal Medicine. 2002;162:2269–76. pmid:12418941
  22. 22. Young GP, Wagner MB, Kellermann AL, Ellis J, Bouley D. Ambulatory visits to hospital emergency departments. Patterns and reasons for use. 24 Hours in the ED Study Group. JAMA. 1996;276:460–5. pmid:8691553
  23. 23. Alishahi Tabriz A, Turner K, Hong Y-R, Gheytasvand S, Powers BD, Elston Lafata J. Trends and Characteristics of Potentially Preventable Emergency Department Visits Among Patients With Cancer in the US. JAMA Network Open. 2023;6:e2250423. pmid:36656584
  24. 24. DeSalvo KB, Fan VS, McDonell MB, Fihn SD. Predicting Mortality and Healthcare Utilization with a Single Question. Health Serv Res. 2005;40:1234–46. pmid:16033502
  25. 25. Cho H, Wang Z, Yabroff KR, Liu B, McNeel T, Feuer EJ, et al. Estimating life expectancy adjusted by self-rated health status in the United States: national health interview survey linked to the mortality. BMC Public Health. 2022;22:141. pmid:35057780
  26. 26. Zajacova A, Lawrence EM. The relationship between education and health: reducing disparities through a contextual approach. Annu Rev Public Health. 2018;39:273–89. pmid:29328865
  27. 27. NIOSH Study Examines Relationship between Employment Status, Healthcare Access, and Health Outcomes [Internet]. 2022 [cited 2024 Jan 31]. https://www.cdc.gov/niosh/updates/upd-11-18-21.html
  28. 28. High-Need, Socially Isolated Adults Have More Problems, but Less Support [Internet]. [cited 2024 Jan 31]. https://www.commonwealthfund.org/blog/2018/sick-and-alone-high-need-socially-isolated-adults-have-more-problems-less-support
  29. 29. Allen EM, Call KT, Beebe TJ, McAlpine DD, Johnson PJ. Barriers to Care and Health Care Utilization Among the Publicly Insured. Med Care. 2017;55:207–14. pmid:27579910
  30. 30. Wray CM, Khare M, Keyhani S. Access to Care, Cost of Care, and Satisfaction With Care Among Adults With Private and Public Health Insurance in the US. JAMA Network Open. 2021;4:e2110275. pmid:34061204
  31. 31. Vashi AA, Fox JP, Carr BG, D’Onofrio G, Pines JM, Ross JS, et al. Use of hospital-based acute care among patients recently discharged from the hospital. JAMA. 2013;309:364–71. pmid:23340638
  32. 32. Collins LM, Lanza ST. Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences [Internet]. John Wiley and Sons Inc.; 2010 [cited 2024 Jan 25]. http://www.scopus.com/inward/record.url?scp=84947792120&partnerID=8YFLogxK
  33. 33. Oberski D. Mixture Models: Latent Profile and Latent Class Analysis. In: Robertson J, Kaptein M, editors. Modern Statistical Methods for HCI [Internet]. Cham: Springer International Publishing; 2016 [cited 2024 Jan 25]. p. 275–87.
  34. 34. Weller BE, Bowen NK, Faubert SJ. Latent Class Analysis: A Guide to Best Practice. Journal of Black Psychology. 2020;46:287–311.
  35. 35. Masyn KE. Latent class analysis and finite mixture modeling. The Oxford handbook of quantitative methods: Statistical analysis, Vol 2. New York, NY, US: Oxford University Press; 2013. p. 551–611.
  36. 36. Wang M-C, Deng Q, Bi X, Ye H, Yang W. Performance of the entropy as an index of classification accuracy in latent profile analysis: A Monte Carlo simulation study. Acta Psychologica Sinica. 2017;49:1473–82.
  37. 37. Sinha P, Calfee CS, Delucchi KL. Practitioner’s Guide to Latent Class Analysis: Methodological Considerations and Common Pitfalls. Crit Care Med. 2021;49:e63–79. pmid:33165028
  38. 38. Glenn BA, Crespi CM, Rodriguez HP, Nonzee NJ, Phillips SM, Sheinfeld Gorin SN, et al. Behavioral and Mental Health Risk Factor Profiles among Diverse Primary Care Patients. Prev Med. 2018;111:21–7. pmid:29277413
  39. 39. Wong CR, Crespi CM, Glenn B, May FP, Han S-HB, Bastani R, et al. Prevalence of Healthcare Barriers among US Adults with Chronic Liver Disease Compared to Other Chronic Diseases. Gastro Hep Advances. 2024;S2772572324000700. pmid:39280913
  40. 40. Fink M, Klein K, Sayers K, Valentino J, Leonardi C, Bronstone A, et al. Objective Data Reveals Gender Preferences for Patients’ Primary Care Physician. J Prim Care Community Health. 2020;11:2150132720967221. pmid:33111633
  41. 41. Nation’s physician workforce evolves: more women, a bit older, and toward different specialties [Internet]. AAMC. [cited 2024 Jul 25]. https://www.aamc.org/news/nation-s-physician-workforce-evolves-more-women-bit-older-and-toward-different-specialties
  42. 42. Hsiang WR, Lukasiewicz A, Gentry M, Kim C-Y, Leslie MP, Pelker R, et al. Medicaid Patients Have Greater Difficulty Scheduling Health Care Appointments Compared With Private Insurance Patients: A Meta-Analysis. Inquiry. 2019;56:0046958019838118. pmid:30947608
  43. 43. Rust G, Ye J, Baltrus P, Daniels E, Adesunloye B, Fryer GE. Practical Barriers to Timely Primary Care Access: Impact on Adult Use of Emergency Department Services. Archives of Internal Medicine. 2008;168:1705–10. pmid:18695087
  44. 44. Ayyala-Somayajula D, Dodge JL, Farias A, Terrault N, Lee BP. Healthcare affordability and effects on mortality among adults with liver disease from 2004 to 2018 in the United States. J Hepatol. 2023;79:329–39. pmid:36996942
  45. 45. Himmelstein DU, Dickman SL, McCormick D, Bor DH, Gaffney A, Woolhandler S. Prevalence and Risk Factors for Medical Debt and Subsequent Changes in Social Determinants of Health in the US. JAMA Network Open. 2022;5:e2231898. pmid:36112374